360 HCP
LIVE

Serial Number

79149276

Owner

BioGenes GmbH

Attorney

Bruce S. Londa

Filing Date

Jan 30, 2014

Add to watchlist:

No watchlists yet
View on USPTO

360 HCP Trademark

Serial Number: 79149276 • Registration: 4693878

360 HCP is a trademark filed by BioGenes GmbH on January 30, 2014. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BioGenes GmbH (2 trademarks)

Köpenicker Str. 325

Entity Type: 99

Trademark Details

Filing Date

January 30, 2014

Registration Date

March 3, 2015

Published for Opposition

December 16, 2014

Goods & Services

[ Services of a biologist, chemistry or biochemistry services, namely, biochemical research and development, custom design and development of biochemical assays; services of a bacteriological, molecular-biological or chemical laboratory, namely, research and testing and scientific laboratory services; research, development and corresponding consultancy in the field of diagnostics, in particular product development of reagents and test kits, in particular on serological and immunogenic basis for the chemistry, biochemistry, bacteriology and biotechnology fields; conducting scientific testing and analysis in the field of virus diagnostics for determining contaminations in the production of active substances; development of testing methods and test kits for the chemistry, biochemistry, bacteriology and biotechnology fields; services in the field of technical and scientific supports, namely, scientific testing of immunoassays for determining contaminations of biological active substances and related diagnostic services in the field of research related thereto; biotechnological services, namely, research and development in the biotechnology field; consultancy relating to chemical and pharmaceutical research, consultancy relating to the development of diagnostic tests and procedures for the chemistry, biochemistry, bacteriology and biotechnology fields ]

Laboratory equipment, namely, antibody-coated laboratory worktops and microtiter plates, in particular for specifying cell type

[ Chemicals and chemical preparations for industrial and scientific use; ] in-vitro diagnostic preparations used in science, in particular for industrial and scientific use; chemical test kits, consisting of immunological or marked antibodies and related reagents on serological and immunogenic basis and reagents therefor for quality control analysis of biological pharmaceutics for laboratory or research use; reagent kits comprised of reagents for scientific or research purposes for conducting the enzyme-linked immune adsorption test (ELISA) not for medical or veterinary purposes; [ chemical preparations for scientific purposes in form of buffers, salts, solvents and reactants for the afore-mentioned test kits; ] chemical reagents for non-medical purposes for buffer solutions used in assay kits; antibody solutions and conjugates and derivatives made from them, namely, biochemical for in vitro and in vivo scientific use; biochemical reagents for use in laboratories [ ; chemical, biochemical or biological preparations and chemical reagents and kits made thereof for the detection of cancer conditions, neoplastic conditions, inflammation conditions, infection conditions, degenerative conditions, genetically abnormal or morbid conditions, proliferative abnormal or morbid conditions, vascular diseases, premalignant conditions, malignant conditions, cancer and congenital defects, all for scientific and research purposes ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 23, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 23, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Jun 23, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 18, 2025 APRE
TEAS SECTION 71 RECEIVED
Mar 5, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 3, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Feb 1, 2024 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Jun 5, 2022 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 5, 2022 INPS
INVALIDATION PROCESSED
Apr 4, 2022 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 17, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 17, 2021 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Mar 17, 2021 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 16, 2021 APRE
TEAS SECTION 71 RECEIVED
Feb 12, 2021 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 3, 2020 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2020 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 17, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 30, 2015 FICS
FINAL DISPOSITION PROCESSED
Jun 30, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 3, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 3, 2015 R.PR
NOTIFICATION PROCESSED BY IB
Dec 19, 2014 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2014 NPUB
PUBLISHED FOR OPPOSITION
Dec 16, 2014 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 3, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 10, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2014 CRFA
ASSIGNED TO LIE
Oct 27, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2014 TROA
REFUSAL PROCESSED BY IB
Aug 22, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 1, 2014 RFCS
REFUSAL PROCESSED BY MPU
Aug 1, 2014 RFRR
APPLICATION FILING RECEIPT MAILED
Aug 1, 2014 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 31, 2014 RFCR
NON-FINAL ACTION WRITTEN
Jul 30, 2014 CNRT
ASSIGNED TO EXAMINER
Jul 28, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 21, 2014 REPR